| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $35.16M | - | |
| CEO | 411.2K | $33.48M | - | |
| CFO | 230.9K | $18.79M | - | |
| VP | 158.5K | $12.90M | - | |
| Other | 91.3K | $7.43M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2015 | Marken James G.47 | Vice President, Operations | Sell | 3,500 | $43.26 | $151,410.00 | -7.1% | |
| Nov 12, 2015 | Przybyl Arthur | President And CEO | Buy | 2,500 | $40.95 | $102,375.00 | +1.8% | |
| Mar 19, 2015 | Marken James G.47 | Vice President, Operations | Sell | 15,000 | $66.50 | $997,500.00 | -32.2% | |
| Mar 12, 2015 | Marshbanks Tracy | Director | Sell | 210,000 | $63.00 | $13,230,000.00 | -27.6% | |
| Mar 12, 2015 | Raynor Daniel | Director | Sell | 200,000 | $63.00 | $12,600,000.00 | -38.2% | |
| Mar 12, 2015 | Arnold Charlotte C. | Vice President And CFO | Sell | 45,000 | $63.00 | $2,835,000.00 | -67.8% | |
| Mar 12, 2015 | Przybyl Arthur | President And CEO | Sell | 75,000 | $63.00 | $4,725,000.00 | -39.6% | |
| Mar 12, 2015 | Meridian Venture Partners II LP | 10% Owner | Sell | 300,000 | $63.00 | $18,900,000.00 | -11.3% |